Chemical Computing Group
Will Krawszik is an experienced professional in the scientific and engineering sectors, currently serving as the Scientific Services Manager and Applications Scientist at Chemical Computing Group since May 2021. Will is the founder of Opportune Therapeutics, which has been operational since June 2018. Previously, Will co-founded and held the position of Operations Director at Moleculomics from December 2012 to June 2018, and worked as an Outreach Mentor at HPC Wales from September 2012 to May 2015. Will's academic background includes a PhD from Swansea University (2007-2009) and a BEng in Automotive Engineering from Oxford Brookes University (2000-2005). Early career experience includes roles as a Design Engineer at Trelleborg Offshore (2006-2007) and TVR Manufacturing Ltd (2003-2006), as well as serving as an Innovation Fellow at the University of Wales from February 2009 to August 2012.
This person is not in the org chart
Chemical Computing Group
CCG (Chemical Computing Group) is a leading supplier of software solutions for life sciences. With a proven track record in scientific innovation, CCG continues to provide state of the art applications in drug discovery to pharmaceutical, biotechnology and academic researchers. CCG headquarters are in Montreal (Canada), with support offices in North America, Europe and Asia. CCG’s software programs include: 1) Molecular Operating Environment (MOE) - a single package for visualization, molecular modeling, computer-aided molecular design (CAMD), cheminformatics, bioinformatics and methodology development. 2) PSILO® - Protein SILO - a database system that provides an easily accessible, consolidated repository for macromolecular and protein-ligand structural information as well as a means to systematically track, register and search both experimental and computational macromolecular structural data. CCG has a strong academic presence with MOE and PSILO® being used extensively in teaching and research in over 600 universities world wide. CCG's special programs and discounts encourage the adoption of computational life science methodologies by the scientific community.